Genomics

Dataset Information

First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial


ABSTRACT: First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial

PROVIDER: PRJNA988032 | ENA |

REPOSITORIES: ENA